Hoth Therapeutics Files S-1 for Potential Stock Offering

TL;DR

Hoth Therapeutics just filed an S-1, get ready for a potential stock sale.

AI Summary

Hoth Therapeutics, Inc. filed an S-1 registration statement on April 11, 2024, indicating plans to offer securities. The company, incorporated in Nevada with its principal executive offices in New York, operates in the Pharmaceutical Preparations sector. This filing is part of their process to potentially raise capital through the sale of stock.

Why It Matters

This S-1 filing signals Hoth Therapeutics' intention to access public markets, which could lead to new funding for its pharmaceutical development or other corporate initiatives.

Risk Assessment

Risk Level: medium — S-1 filings often precede stock offerings, which carry inherent market risks and dilution potential for existing shareholders.

Key Numbers

• 333-278620 — SEC File Number (Identifies this specific registration statement with the SEC.)
• 24838712 — Film Number (Internal SEC processing number for the filing.)

Key Players & Entities

• Hoth Therapeutics, Inc. (company) — Registrant
• April 11, 2024 (date) — Filing Date
• Nevada (jurisdiction) — State of Incorporation
• New York (location) — Principal Executive Offices
• 2834 (sic_code) — Standard Industrial Classification
• Robb Knie (person) — Chief Executive Officer
• Richard A. Friedman (person) — Legal Counsel
• Emily A. Mastoloni (person) — Legal Counsel
• Sheppard, Mullin, Richter & Hampton LLP (company) — Legal Counsel Firm

FAQ

From the Filing

0001213900-24-032207.txt : 20240411 0001213900-24-032207.hdr.sgml : 20240411 20240411161549 ACCESSION NUMBER: 0001213900-24-032207 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hoth Therapeutics, Inc. CENTRAL INDEX KEY: 0001711786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821553794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-278620 FILM NUMBER: 24838712 BUSINESS ADDRESS: STREET 1: 590 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (646)756-2997 MAIL ADDRESS: STREET 1: 590 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 S-1 1 ea0203284-s1_hoththerape.htm REGISTRATION STATEMENT As filed with the Securities and Exchange Commission April 11, 2024 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HOTH THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Nevada 2834 82-1553794 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 590 Madison Ave., 21 st Floor New York, NY 10022 (646) 756-2997 (Address and telephone number of registrant’s principal executive offices) Robb Knie Hoth Therapeutics, Inc. Chief Executive Officer 590 Madison Ave., 21 st Floor New York, NY 10022 (646) 756-2997 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Richard A. Friedman, Esq. Emily A. Mastoloni, Esq. Sheppard, Mullin, Richter & Hampton LLP 30 Rockefeller Plaza New York, NY 10112 Tel: (212) 653-8700 Fax: (212) 653-8701 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐ The Registrant hereby amends this Registration Statement on such date o